title: Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma.
authors.affiliation: John Wayne Cancer Institute, Saint John's Hospital and Health Center, Santa Monica, California 90404.
authors.forename: D L
authors.initials: DL
authors.lastname: Morton
authors.forename: D S
authors.initials: DS
authors.lastname: Hoon
authors.forename: J A
authors.initials: JA
authors.lastname: Nizze
authors.forename: L J
authors.initials: LJ
authors.lastname: Foshag
authors.forename: E
authors.initials: E
authors.lastname: Famatiga
authors.forename: L A
authors.initials: LA
authors.lastname: Wanek
authors.forename: C
authors.initials: C
authors.lastname: Chang
authors.forename: R F
authors.initials: RF
authors.lastname: Irie
authors.forename: R K
authors.initials: RK
authors.lastname: Gupta
authors.forename: R
authors.initials: R
authors.lastname: Elashoff
mesh_terms: D000912:Antibodies, Neoplasm / Q000096:biosynthesis; D000951:Antigens, Neoplasm / Q000276:immunology; D003429:Cross Reactions; D005732:Gangliosides / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D016233:Immunotherapy, Active; D008545:Melanoma / Q000628:therapy*; D009362:Neoplasm Metastasis; D016019:Survival Analysis
chemical_list: D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D005732:Gangliosides